Orlinger Klaus 4
4 · HOOKIPA Pharma Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2024-04-15+367,300→ 367,300 totalExercise: $0.76Exp: 2034-04-15→ Common Stock (367,300 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.